References
Network NCC. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. Retrieved 2 April 2021 at https://jnccn.org/view/journals/jnccn/16/6/article-p742.xml?ArticleBodyColorStyles=pdf-5590.
Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100. https://doi.org/10.1126/science.1152586.
Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res. 2010;70:8388–97. https://doi.org/10.1158/0008-5472.CAN-10-2128.
Paulson KG, Lewis CW, Redman MW, et al. Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study. Cancer. 2017;123:1464–74. https://doi.org/10.1002/cncr.30475.
Arroyave AJ, Lewis JM, Landry M, McLoughlin JM, Enomoto LM. Merkel cell polyomavirus antibody titer predicts recurrence-free survival. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11008-8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arroyave, A.J., Enomoto, L.M. ASO Author Reflections: The Evolving and Expanding Role of Merkel Cell Polyomavirus Antibody Titers. Ann Surg Oncol 29, 1627–1628 (2022). https://doi.org/10.1245/s10434-021-11013-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11013-x